StockNews.com Initiates Coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY)

Stock analysts at StockNews.com assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also commented on ALNY. Sanford C. Bernstein cut their price objective on shares of Alnylam […]

Related Keywords

Sanfordc Bernstein ,Yvonne Greenstreet ,Pushkal Garg ,Capital Advisors Ltd ,Kb Financial Partners ,Belpointe Asset Management ,Securities Exchange Commission ,Hedge Funds Weigh In On Alnylam Pharmaceuticals ,News Ratings For Alnylam Pharmaceuticals Daily ,Alnylam Pharmaceuticals Stock ,Archer Investment Corp ,Alnylam Pharmaceuticals ,Analyst Recommendations For Alnylam Pharmaceuticals ,Morgan Stanley ,Needham Company ,Citigroup ,Alnylam Pharmaceuticals Inc ,Get Free Report ,Exchange Commission ,Asset Management ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Initiated Coverage ,Stocknews Com ,